Xeris Pharmaceuticals is Drug Discovery in United States that focus on Xeris Pharmaceuticals Inc business. Founded in 2005. They cover business area such as Xeris Pharmaceuticals Inc, its novel non-aqueous formulation technology platform, XeriSol, XeriJect, injectable and infusible drug formulation, its pipeline product, Diazepam, Pramlintide-Insulin, Self-Administered Glucagon.
2005
( 19 years old in 2024 )
Xeris Pharmaceuticals Inc
-
180 North LaSalle Street
Suite 1600
Chicago, IL 60601
United States
Private
Xeris Pharmaceuticals Incits novel non-aqueous formulation technology platformXeriSolXeriJectinjectable and infusible drug formulationits pipeline productDiazepamPramlintide-InsulinSelf-Administered Glucagon
* We use standard office opening hours in near Xeris Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Xeris Pharmaceuticals is Drug Discovery business from United States that founded in 2005 (19 years old in 2024), Xeris Pharmaceuticals business is focusing on Xeris Pharmaceuticals Inc.
Xeris Pharmaceuticals headquarter office and corporate office address is located in 180 North LaSalle Street Suite 1600 Chicago, IL 60601 United States.
Xeris Pharmaceuticals was founded in United States.
In 2024, Xeris Pharmaceuticals is currently focus on Xeris Pharmaceuticals Inc sector.
Above is snippet of Google Trends for "Xeris Pharmaceuticals Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Xeris Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
